19 February 2019

The Nature Microbiology paper by the CMBI researchers Daniel Garza, Martijn Huynen, and Bas Dutilh won the first place in the paper award session of the Tumors of the digestive tract research theme.

The paper competed with six other recent publications produced by radboudumc research groups that had PhD candidates as first authors. The first authors were invited to give a short pitch and the public voted and selected our publication as the best paper/pitch.


 

Related news items


Renee Salz wins prize for best presentation

10 May 2022

Renee Salz won the award for best oral presentation during the Rolduc genetics retreat, organized by the Dutch and Belgian Societies of Human Genetics in Brugge. Her presentation was titled "Variant effect prediction based on long read transcriptomes".

read more

Large NWA ORC grant awarded for national skin research: Next Generation ImmunoDermatology

23 March 2022

Research for better treatment methods for chronic skin diseases.

read more

Novel high-resolution targeted sequencing of the cervicovaginal microbiome published in the Journal of BMC Biology

28 December 2021

This project of William Melchers, Karolina Andralojc and Mariano Molina describe a novel sequencing method to profile the cervicovaginal microbiome at the species level and with the potential to elucidate the role of the microbiome in hrHPV-induced carcinogenesis.

read more

DeepRank: a deep learning framework for data mining 3D protein-protein interfaces

8 December 2021

Li Xue and colleagues recently published ''DeepRank, a deep learning framework for data mining 3D protein-protein structures'' in Nature Communications.

read more

Sponsor walk Prinses Beatrix Spierfonds

28 October 2021

CMBI researchers Sylvia Nieuwenhuis, Nawel van Lin, Paul Blom and Peter-Bram 't Hoen raised money for the Prinses Beatrix Spierfonds.

read more

ScreenPoint Medical raises $28 million for further development Series C funding led by Insight Partners

2 August 2021

ScreenPoint Medical has raised $28 million in a Series C financing. ScreenPoint Medical is a spin-off of the Radboudumc.

read more